Dr. Kathryn Tinckam is the Medical Director of the HLA Laboratory and a transplant nephrologist at the University Health Network, , and an Associate Professor of Medicine and Laboratory Medicine at the University of Toronto. She is also Medical Advisor in Transplantation for Canadian Blood Services, responsible for interprovincial listing and allocation and the Canadian Transplant Registry clinical programs, and is the Secretary of the Canadian Society of Transplantation.
She received her undergraduate medical education and Internal Medicine training at the University of Manitoba, her nephrology and transplant training at UBC and completed a fellowship in Histocompatibility and Immunogenetics at Harvard University.
Her clinical and research interests encompass the standardization of HLA laboratory testing, clinical programs to increase transplant in highly sensitized patients, the contribution of HLA antibodies to antibody mediated rejection pathways and outcomes and the management of HLA related alloimmune injury.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)